Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.925
-0.025 (-0.85%)
Aug 28, 2025, 12:29 PM - Market open

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $1.00 billion. The enterprise value is $459.75 million.

Market Cap1.00B
Enterprise Value 459.75M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Nuvation Bio has 342.27 million shares outstanding. The number of shares has increased by 43.14% in one year.

Current Share Class 341.27M
Shares Outstanding 342.27M
Shares Change (YoY) +43.14%
Shares Change (QoQ) +0.63%
Owned by Insiders (%) 24.91%
Owned by Institutions (%) 58.69%
Float 231.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 66.31
Forward PS 13.46
PB Ratio 2.71
P/TBV Ratio 2.80
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 32.03
EV / EBITDA 2.28
EV / EBIT 2.29
EV / FCF n/a

Financial Position

The company has a current ratio of 9.39, with a Debt / Equity ratio of 0.15.

Current Ratio 9.39
Quick Ratio 9.26
Debt / Equity 0.15
Debt / EBITDA 0.28
Debt / FCF n/a
Interest Coverage 293.03

Financial Efficiency

Return on equity (ROE) is -44.84% and return on invested capital (ROIC) is 25.63%.

Return on Equity (ROE) -44.84%
Return on Assets (ROA) 20.17%
Return on Invested Capital (ROIC) 25.63%
Return on Capital Employed (ROCE) 34.51%
Revenue Per Employee $65,250
Profits Per Employee -$922,264
Employee Count220
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.55% in the last 52 weeks. The beta is 1.35, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y) 1.35
52-Week Price Change -4.55%
50-Day Moving Average 2.36
200-Day Moving Average 2.34
Relative Strength Index (RSI) 66.08
Average Volume (20 Days) 4,665,132

Short Selling Information

The latest short interest is 69.07 million, so 20.18% of the outstanding shares have been sold short.

Short Interest 69.07M
Short Previous Month 71.29M
Short % of Shares Out 20.18%
Short % of Float 29.89%
Short Ratio (days to cover) 15.03

Income Statement

In the last 12 months, Nuvation Bio had revenue of $14.36 million and -$202.90 million in losses. Loss per share was -$0.63.

Revenue14.36M
Gross Profit 3.95M
Operating Income 200.43M
Pretax Income -510.72M
Net Income -202.90M
EBITDA 201.48M
EBIT 200.43M
Loss Per Share -$0.63
Full Income Statement

Balance Sheet

The company has $607.72 million in cash and $57.76 million in debt, giving a net cash position of $549.96 million or $1.61 per share.

Cash & Cash Equivalents 607.72M
Total Debt 57.76M
Net Cash 549.96M
Net Cash Per Share $1.61
Equity (Book Value) 372.91M
Book Value Per Share 1.09
Working Capital 556.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$168.19 million and capital expenditures -$388,000, giving a free cash flow of -$168.58 million.

Operating Cash Flow -168.19M
Capital Expenditures -388,000
Free Cash Flow -168.58M
FCF Per Share -$0.49
Full Cash Flow Statement

Margins

Gross Margin 27.54%
Operating Margin 1,396.27%
Pretax Margin -1,413.43%
Profit Margin n/a
EBITDA Margin 1,403.56%
EBIT Margin 1,396.27%
FCF Margin n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.14%
Shareholder Yield -43.14%
Earnings Yield -20.09%
FCF Yield -16.70%

Analyst Forecast

The average price target for Nuvation Bio is $8.00, which is 173.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 173.50%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 131.26%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Nuvation Bio has an Altman Z-Score of 1.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.6
Piotroski F-Score 4